Poprawa jędrności i elastyczności
Rozświetlenie i wyrównanie kolorytu
Spłycenie zmarszczek i linii
Regeneracja i odbudowa

ETERNA EYE 0.03% encapsulated retinal...

ETERNA EYE 0.03% encapsulated retinal eye cream

Reference 0000000808

zł109.99

Tax included

SKIN CONCERN: FINE AND VISIBLE WRINKLES, LOSS OF FIRMNESS, UNEVEN TEXTURE, DULL AND TIRED-LOOKING EYE AREA; INTRODUCTORY OR ADVANCED RETINAL CARE

FUNCTION: SUPPORTS EPIDERMAL RENEWAL; REDUCES THE APPEARANCE OF WRINKLES; IMPROVES FIRMNESS AND SMOOTHNESS; BRIGHTENS AND REVITALISES THE EYE AREA

SKIN TYPE: ALL SKIN TYPES; 0.03% FOR BEGINNERS, 0.06% FOR USERS WITH ESTABLISHED RETINOID TOLERANCE

ROUTINE STEP: EVENING RETINOID RENEWAL FOR THE EYE AREA. INTRODUCE GRADUALLY AND USE SUN PROTECTION IN THE MORNING.

capacity

15 ml

contration

0,03

Description

ETERNA EYE 0.03%

ETERNA EYE 0.03% is an eye cream with encapsulated retinal at a gentler concentration, designed for the gradual introduction of retinoid care to the delicate eye area. The formula supports epidermal renewal, helps smooth fine lines and improves skin firmness and texture. Retinal enclosed in a phospholipid carrier offers enhanced stability and controlled release. Nano-calcium hydroxyapatite supports skin density, elasticity and resilience, while naringin glucoside provides soothing and antioxidant action. Regular use helps achieve a smoother, more radiant and rested-looking eye area.

How does the ETERNA EYE 0.03% formula work?

Encapsulated retinal 0.03% — an active vitamin A derivative intended for a gentler introduction to retinoid care around the eyes. It supports epidermal renewal, the synthesis of structural proteins and smoother texture, helping reduce fine lines and improve firmness. Encapsulation increases stability and enables gradual ingredient release.
Nano-calcium hydroxyapatite — a biomimetic mineral ingredient that creates a skin-compatible supportive structure. It helps improve the density, elasticity and resilience of thin skin and supports its protective function.
Naringin glucoside — a flavonoid derivative with antioxidant and soothing properties. It helps reduce signs of oxidative stress, improves comfort and supports a brighter, more radiant-looking eye area.
Hydrogenated lecithin — replenishes barrier lipids and forms a delivery system that supports retinal stability and even distribution.

Who is it for?

all skin types; for beginners introducing retinal around the eyes

ETERNA EYE 0.06%

ETERNA EYE 0.06% is an advanced eye cream for users with established retinoid tolerance. Encapsulated retinal supports epidermal renewal, visibly smooths wrinkles and helps improve the firmness of delicate skin around the eyes. The delivery technology increases retinal stability and enables gradual, controlled release. Nano-calcium hydroxyapatite provides biomimetic support for the skin’s structure, improving density, elasticity and resilience. Naringin glucoside soothes and provides antioxidant support, promoting comfort and a more radiant appearance. Regular use helps achieve a smoother, firmer and visibly refreshed eye contour.

How does the ETERNA EYE 0.06% formula work?

Encapsulated retinal 0.06% — an active vitamin A derivative for skin with established retinoid tolerance. It accelerates epidermal renewal, supports collagen synthesis and helps visibly reduce the appearance of wrinkles, unevenness and loss of firmness. Encapsulation increases stability and provides gradual, controlled release.
Nano-calcium hydroxyapatite — a biomimetic mineral ingredient that supports the skin’s architecture. It helps increase density, elasticity and resilience, promoting a firmer and smoother-looking eye area.
Naringin glucoside — provides antioxidant and soothing action, limits the effects of oxidative stress and helps improve skin comfort and radiance.
Hydrogenated lecithin — supports the lipid barrier, improves retinal stability and enables more even delivery to the skin.

Who is it for?

all skin types; for users with established retinoid tolerance

key active ingredients

Variant 0.03%

Encapsulated retinal 0.03% — an active vitamin A derivative intended for a gentler introduction to retinoid care around the eyes. It supports epidermal renewal, the synthesis of structural proteins and smoother texture, helping reduce fine lines and improve firmness. Encapsulation increases stability and enables gradual ingredient release.
Nano-calcium hydroxyapatite — a biomimetic mineral ingredient that creates a skin-compatible supportive structure. It helps improve the density, elasticity and resilience of thin skin and supports its protective function.
Naringin glucoside — a flavonoid derivative with antioxidant and soothing properties. It helps reduce signs of oxidative stress, improves comfort and supports a brighter, more radiant-looking eye area.
Hydrogenated lecithin — replenishes barrier lipids and forms a delivery system that supports retinal stability and even distribution.

Variant 0.06%

Encapsulated retinal 0.06% — an active vitamin A derivative for skin with established retinoid tolerance. It accelerates epidermal renewal, supports collagen synthesis and helps visibly reduce the appearance of wrinkles, unevenness and loss of firmness. Encapsulation increases stability and provides gradual, controlled release.
Nano-calcium hydroxyapatite — a biomimetic mineral ingredient that supports the skin’s architecture. It helps increase density, elasticity and resilience, promoting a firmer and smoother-looking eye area.
Naringin glucoside — provides antioxidant and soothing action, limits the effects of oxidative stress and helps improve skin comfort and radiance.
Hydrogenated lecithin — supports the lipid barrier, improves retinal stability and enables more even delivery to the skin.

EFFECTS

Variant 0.03%

Smooths fine lines and uneven texture around the eyes.
Supports improved firmness, elasticity and density of delicate skin.
Helps brighten the eye area and give it a more rested appearance.

Variant 0.06%

Helps smooth visible wrinkles around the eyes.
Supports improved skin firmness, elasticity and evenness.
Helps achieve a smoother, brighter and visibly revitalised eye contour.

how to use

Variant 0.03%

Apply in the evening to the cleansed eye area. Gently pat in. Introduce gradually, initially 2–3 times a week. Use sun protection in the morning.

Variant 0.06%

Apply in the evening to the cleansed eye area. Gently pat in. Adjust the frequency to your skin’s tolerance. Use sun protection in the morning.

Warnings: Contains vitamin A. Consider your daily intake from all sources before use.

proprietary delivery system

Encapsulation of retinal in phospholipid micelles from hydrated lecithin

TECHNOLOGY DESCRIPTION

The retinal encapsulation technology uses biomimetic phospholipid micelles based on hydrated lecithin, which form stable nanostructures with amphiphilic architecture. The hydrophobic core of the micelles (lipid tails) promotes the incorporation of lipophilic retinal molecules, while the hydrophilic shell allows the system to remain in stable dispersion in an aqueous environment. Due to the limited stability of retinal in classic formulations, micellar technology is a justified approach to its delivery while maintaining high skin compatibility. The biomimetic similarity of lecithin phospholipids to the building blocks of the hydrolipid barrier may promote the integration of nanostructures with skin structures and the deposition of the active substance within the epidermis. The presence of stable nanostructures and their size (on average approx. 50 nm) have been confirmed by transmission electron microscopy (TEM).

Author: Prof. Ewa Olędzka, PhD, Eng. Medical University of Warsaw

Link to the full study

BENEFITS

1. Stabilisation of the active substance in the formulation: incorporation of retinal into the hydrophobic core of the micelles helps to reduce exposure to degrading factors (light, shade, moisture).

2. Controlled release: micellar technology helps reduce uncontrolled, rapid release of the substance after application, which can translate into a more controlled and prolonged action profile

3. Skin compatibility: the biomimetic similarity of lecithin phospholipids to the building blocks of the skin's hydrolipid barrier may promote the integration of nanostructures into skin structures.

4. Potential support for deposition within the epidermis: interactions between the phospholipid carrier and the epidermal barrier lipids may promote the deposition of the active substance within the epidermis.

5. Better skin tolerance: the stabilisation of retinal in the formulation and controlled release may promote better tolerance compared to classic retinoid formulations.

6. Multi-level correction of photoageing symptoms: retinal, the biologically active form of retinoid, promotes the induction of structural protein synthesis and stimulates cell renewal, which can translate into improved skin texture and an even skin tone.